SEC Form 4 · accession 0001179110-18-011047
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jaime Contreras
Officer — Senior Vice President
Period of report
Aug 29, 2018
Accepted (ET)
Aug 31, 2018 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Aug 29, 2018 | S | 1,640 | $66.785 | D | 125,471 | D | |
| Common shares without par value | Aug 29, 2018 | S | 8,895 | $66.79 | D | 116,576 | D | |
| Common shares without par value | Aug 29, 2018 | S | 2,768 | $66.795 | D | 113,080 | D | |
| Common shares without par value | Aug 29, 2018 | S | 2,505 | $66.80 | D | 111,303 | D | |
| Common shares without par value | Aug 29, 2018 | S | 2,463 | $66.805 | D | 108,840 | D | |
| Common shares without par value | Aug 29, 2018 | S | 2,900 | $66.81 | D | 105,940 | D | |
| Common shares without par value | Aug 29, 2018 | S | 600 | $66.815 | D | 105,340 | D | |
| Common shares without par value | Aug 29, 2018 | S | 1,799 | $66.82 | D | 103,541 | D | |
| Common shares without par value | Aug 29, 2018 | S | 200 | $66.825 | D | 103,341 | D | |
| Common shares without par value | Aug 29, 2018 | S | 928 | $66.835 | D | 102,413 | D | |
| Common shares without par value | Aug 29, 2018 | S | 4,116 | $66.84 | D | 98,297 | D | |
| Common shares without par value | Aug 29, 2018 | S | 805 | $66.845 | D | 97,492 | D | |
| Common shares without par value | Aug 29, 2018 | S | 8,335 | $66.85 | D | 89,157 | D | |
| Common shares without par value | Aug 29, 2018 | S | 840 | $66.855 | D | 88,317 | D | |
| Common shares without par value | Aug 29, 2018 | S | 14,800 | $66.86 | D | 73,517 | D | |
| Common shares without par value | Aug 29, 2018 | S | 474 | $66.865 | D | 73,043 | D | |
| Common shares without par valueF1 | Aug 29, 2018 | S | 10,200 | $66.87 | D | 54,968 | D | |
| Common shares without par valueF2 | holding | — | — | — | 22 | I | Profit Sharing Trust | |
| Common shares without par valueF3 | holding | — | — | — | 72,172 | I | Jaime Contreras Marvan 2006 Living Trust | |
| Common shares without par valueF4 | holding | — | — | — | 2,595 | I | By Spouse | |
| Common shares without par valueF5 | holding | — | — | — | 12,081 | I | Living Trust (by spouse) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Excludes 7,875 shares previously directly owned which were transferred to the Jaime Contreras Marvan 2006 Living Trust on July 6, 2018.
- F2Balance in the Abbott Laboratories Stock Retirement Trust as of August 29, 2018.
- F3Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
- F4The reporting person disclaims beneficial ownership of all securities held by his spouse.
- F5Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 2 of 2.